Deutsche Bank’s Edesa Biotech EDSA Stock Holding History

Deutsche Bank’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,430	Closed	-$41K	–	4448
2019 Q4	$41K	Buy	1,430 +1,264	+761%	+$44.7K	﹤0.01%	4045
2019 Q3	$7K	Buy	+166	New	+$6.03K	﹤0.01%	4582
2018 Q4	–	Sell	-12	Closed	-$1K	–	5208
2018 Q3	$1K	Buy	+12	New	+$764	﹤0.01%	5277
2018 Q1	–	Sell	-169	Closed	-$40K	–	5448
2017 Q4	$40K	Buy	169 +163	+2,717%	+$51.9K	﹤0.01%	4514
2017 Q3	$1K	Buy	+6	New	+$2.18K	﹤0.01%	4819
2016 Q2	–	Sell	-2	Closed	-$3K	–	5215
2016 Q1	$3K	Buy	+2	New	+$3.5K	﹤0.01%	5010

Other funds holding EDSA

BBA

Braun-Bostich & Associates Canonsburg, Pennsylvania $179M AUM 21.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank's EDSA Position: Q1 2020 in Review

Deutsche Bank sold out of Edesa Biotech (EDSA) in Q1 2020, closing a stake of 1,430 shares — an estimated $41K sold.

Deutsche Bank first reported a position in EDSA in Q1 2016 and held it in 6 quarters. The position peaked at $41K in Q4 2019. 8 funds tracked by Wall St. Rank hold EDSA as of Q1 2020.

Deutsche Bank reported no remaining Edesa Biotech position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 1,430 Edesa Biotech shares in Q1 2020, an estimated $41K.
Deutsche Bank first reported a position in Edesa Biotech in Q1 2016 and held it in 6 quarters.
Deutsche Bank's Edesa Biotech position peaked at $41K in Q4 2019.
8 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.